Close

Ratings by Oppenheimer (Leland Gershall)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/30/2022 Trevi Therapeutics TRVI Maintain Outperform
(N/A)
 
 
  Details
6/29/2022 Trevi Therapeutics TRVI Maintain Outperform
(Outperform)
 
 
  Details
6/6/2022 NuCana NCNA Maintain Outperform
(Outperform)
 
 
  Details
5/25/2022 Trevi Therapeutics TRVI New Coverage Outperform
(N/A)
2.25
(1.75)
-22.22% Details
3/14/2022 NuCana NCNA Maintain Outperform
(N/A)
 
 
  Details
2/3/2022 NuCana NCNA Maintain Outperform
(Outperform)
 
 
  Details
3/5/2021 NuCana NCNA Maintain Outperform
(N/A)
 
 
  Details
11/30/2020 NuCana NCNA Maintain Outperform
(N/A)
 
 
  Details
8/21/2020 NuCana NCNA Maintain Outperform
(N/A)
 
 
  Details
7/24/2020 NuCana NCNA New Coverage Outperform
(N/A)
5.22
(0.98)
-81.23% Details